Bio-Rad Laboratories, Inc.Class A (BIO) Stock Price, Quote & AI Analysis
Live BIO stock price, real-time charts, AI-powered trade signals, technical analysis, earnings insights, and market sentiment for Bio-Rad Laboratories, Inc.Class A.
TradeVae provides AI-driven analysis and real-time market intelligence for Bio-Rad Laboratories, Inc.Class A (BIO), including price action, technical indicators, earnings performance, analyst sentiment, and short-term trade setups.
AI Analysis
Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.
Generating AI analysis...
Bio-Rad Laboratories, Inc.Class A's fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.
Bio-Rad Laboratories, Inc.Class A Overview
Company information
Company Overview
Bio-Rad Laboratories, Inc. engages in the development and production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications. It operates through the Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets reagents, apparatus, and laboratory instruments. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, and test kits. The company was founded by David S. Schwartz and Alice N. Schwartz in 1952 and is headquartered in Hercules, CA.
Company Details
Technical Indicators
Key technical analysis metrics and signals
Loading technical indicators...
Valuation Metrics
Key valuation ratios and comparisons
Loading valuation metrics...
Bio-Rad Laboratories, Inc.Class A Earnings & Financial Statements
Earnings Calendar
Upcoming earnings dates and historical surprises
Loading earnings calendar...
Financial Statements
Income statements, balance sheets, and cash flow
Loading income statements...
Loading balance sheets...
Loading cash flow statements...